[1]
L. Testa, “PHASE II CLINICAL TRIAL, TESTING THE EFFICACY OF A HUMANIZED MONOCLONAL ANTIBODY AGAINST THE LEWIS-Y ANTIGEN (LE Y)”, MAST, vol. 28, p. 11, jun. 2018.